In vivo detection of MCMV miRNAs by nuclease protection assay. (A) Five micrograms of RNA extracted from the livers, lungs, and spleens of two noninfected mice or three mice i.v. infected with 5 × 106 PFU MCMV for 3 days (lanes A, B, and C) or 5 days (lanes D, E, and F) were hybridized to a radiolabeled probe complementary to miR-m01-4 or miR-M44-1, digested with nuclease S1, and loaded on a denaturing acrylamide gel. The arrows indicate the expected positions of the protected fragment. ND, not digested; Neg, negative-control yeast RNA; M1 and M2, RNA from mock-infected mouse 1 and mouse 2, respectively; Pos, RNA from NIH 3T3 cells infected by MCMV; dpi, days postinfection. (B) Time course of infectious virus present in different organs of BALB/c mice i.v. infected with 1 × 106 PFU MCMV. Five mice were infected per group. The livers, lungs, and spleens were taken at 1, 3, 5, and 7 days postinfection. The titers of infectious virus were determined by titrating organ homogenates using centrifugal enhancement (30 min. at 800 × g) and a standard plaque assay. The broken lines indicate the detection limit, and the short black lines indicate the median value.